Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EEF1AKMT1 Antibody | Login | EEF1AKMT1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| LACE1 Antibody | Login | LACE1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ZDHHC20 Antibody | Login | ZDHHC20 Antibody | ||||||||||||||||
|
||||||||||||||||||
| FBXW12 Antibody | Login | FBXW12 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CCDC36 Antibody | Login | CCDC36 Antibody | ||||||||||||||||
|
||||||||||||||||||
| SYT10 Antibody | Login | SYT10 Antibody | ||||||||||||||||
|
||||||||||||||||||
| VHLL Antibody | Login | VHLL Antibody | ||||||||||||||||
|
||||||||||||||||||
| CUEDC2 Antibody - C-terminal region | Login | CUEDC2 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| NOX5 Antibody - C-terminal region | Login | NOX5 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| HRPT2 Antibody | Login | HRPT2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| AGER Antibody (OABF00086-100UL) | Login | AGER Antibody (OABF00086-100UL) | ||||||||||||||||
|
||||||||||||||||||
| TLR10 Antibody - N-terminal region | Login | TLR10 Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
| SYVN1 Antibody (OABF00255-100UL) | Login | SYVN1 Antibody (OABF00255-100UL) | ||||||||||||||||
|
||||||||||||||||||
| LYRIC Antibody | Login | LYRIC Antibody | ||||||||||||||||
|
||||||||||||||||||
| FOXP1 Antibody (OABF00598-100UL) | Login | FOXP1 Antibody (OABF00598-100UL) | ||||||||||||||||
|
||||||||||||||||||
| NLRP3 Antibody (OABF00351-100UL) | Login | NLRP3 Antibody (OABF00351-100UL) | ||||||||||||||||
|
||||||||||||||||||
| RBFOX3 Antibody (OABF00775-100UL) | Login | RBFOX3 Antibody (OABF00775-100UL) | ||||||||||||||||
|
||||||||||||||||||
| TICAM1 Antibody - C-terminal region | Login | TICAM1 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
| IL23R Antibody (OABF00713-100UL) | Login | IL23R Antibody (OABF00713-100UL) | ||||||||||||||||
|
||||||||||||||||||
| BTLA Antibody (OABF00226-100UL) | Login | BTLA Antibody (OABF00226-100UL) | ||||||||||||||||
|
||||||||||||||||||
| ENPP3 Antibody (OABF00760-100UL) | Login | ENPP3 Antibody (OABF00760-100UL) | ||||||||||||||||
|
||||||||||||||||||
| CDKN1C Antibody (OABF00187-100UL) | Login | CDKN1C Antibody (OABF00187-100UL) | ||||||||||||||||
|
||||||||||||||||||
| ADIPOQ Antibody | Login | ADIPOQ Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRKACB Antibody (OABF00178-100UL) | Login | PRKACB Antibody (OABF00178-100UL) | ||||||||||||||||
|
||||||||||||||||||
| HYAL1 Antibody (OABF00583-100UL) | Login | HYAL1 Antibody (OABF00583-100UL) | ||||||||||||||||
|
||||||||||||||||||


